Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Moderate to Severe Palmoplantar Psoriasis
NCT02400749Phase 4Completed
- Sponsor
- Innovaderm Research
- Start
- May 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of apremilast in palmoplantar psoriasis, sponsored by Innovaderm Research. Started May 2015; status: completed.
02
Drugs
apremilast
03
Conditions
palmoplantar psoriasis
Beyond the preview
Go deeper on NCT02400749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400749.